New Delhi, Jan 29 (PTI) The initial public offer of Temasek Holdings and TPG-backed Dr Agarwal's Health Care Ltd, an eye care services provider, received 7 per cent subscription on the first day of bidding on Wednesday.

The public issue got bids for 38,08,980 shares against 5,35,26,172 shares on offer, as per NSE data.

Also Read | Shillong Teer Results Today, January 29 2025: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

The portion for Retail Individual Investors (RIIs) fetched 11 per cent subscription while the category for non-institutional investors received 6 per cent subscription.

Dr Agarwal's Health Care on Tuesday said it has raised over Rs 875.5 crore from anchor investors.

Also Read | What Is Duare Sarkar Initiative of West Bengal Government? How Do Duare Sarkar Camps Operate To Ensure Delivery of Welfare Schemes' Benefits?.

The Rs 3,027.26-crore public issue, with a price band of Rs 382 to Rs 402 per share, will conclude on January 31.

The IPO is a combination of a fresh issue of up to Rs 300 crore and an Offer For Sale (OFS) of up to 6.78 crore equity shares worth Rs 2,727.26 crore by promoters and other selling shareholders at the upper end of the price band.

Those selling shares in the OFS include Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.

Proceeds from the fresh issue to the tune of Rs 195 crore will be used for payment of debt. Besides, a portion will be used for general corporate purposes and unidentified inorganic acquisitions.

Dr Agarwal's Health Care offers a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

As of September 2024, its network consisted of 193 facilities with a majority concentration in South India, particularly Chennai, Hyderabad and Bengaluru, followed by Western India.

Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal Investment Advisors are the book-running lead managers to the issue.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)